Advertisement
Home Blog Page 2969
Apixaban therapy is cost-effective for atrial fibrillation from the perspective of the U.S. health care system

Apixaban Tx Cost in A-Fib Meets U.S. Norms for Reasonable Value

0
Incremental cost of achieving longer life expectancy within accepted U.S. norm ($53,925/QALY)
For Chinese

Effect of AMD on Vision-Specific Functioning Differs by Ethnicity

0
Early and late age-related macular degeneration tied to worse VSF for Chinese, not Indian, Malay adults
Among infants born from 23 to 34 weeks of gestation

Extreme Preemies Benefit Most From Corticosteroids Before Birth

0
Effect size of corticosteroid exposure on mortality greater at lowest gestations
Admission to an invasive heart center and regional performance of acute coronary angiography/percutaneous coronary intervention are associated with improved survival in out-of-hospital cardiac arrest patients

Invasive Heart Center Admission Best for Cardiac Arrest Survival

0
Distance from the site of cardiac arrest to the center does not affect outcomes
Factors associated with poor primary care coordination include chronic conditions and younger age

Factors Associated With Poor Primary Care Coordination ID’d

0
Increased likelihood of poor care coordination for patients with chronic care conditions, <65 years
There seems to be a positive association for extremely low-frequency magnetic fields exposure with amyotrophic lateral sclerosis mortality in men

Extremely Low-Frequency Magnetic Fields Tied to ALS Death

0
Possible association for ALS mortality with occupational exposure to ELF-MFs in men
From 2001-2002 to 2012-2013 there was an increase in the prevalence of heroin use and heroin use disorder

Increases in Heroin Use in the U.S. Greater Among Whites

0
Increase in prevalence of heroin use, heroin use disorder, with increase more pronounced in whites
For women with early-stage unilateral breast cancer treated with surgery

Contralateral Prophylactic Mastectomy Rates Up Nationwide

0
Increase seen in all states from 2004 to 2012, with greatest increases in five contiguous Midwest states
For patients undergoing percutaneous coronary intervention

Target-Vessel Failure Rate Similar for Scaffold, Stent in PCI

0
Increased two-year event rate of definite or probable device thrombosis for scaffold versus stent group
Enteral docosahexaenoic acid supplementation does not reduce the risk of bronchopulmonary dysplasia for infants born before 29 weeks of gestation

Enteral DHA Doesn’t Cut Preemie Bronchopulmonary Dysplasia Risk

0
Relative risk of physiological bronchopulmonary dysplasia up for infants born before 29 weeks